Carotuximab has been investigated for the treatment of Metastatic NSCLC, Recurrent Ovarian, Fallopian Tube, Primary Peritoneal Carcinoma, Advanced Soft Tissue Sarcoma, Hepatocellular Carcinoma, Glioblastoma, Glioblastoma Multiforme, Metastatic Breast Cancer and Advanced Angiosarcoma.
There are no reviews yet.
Your email address will not be published. Required fields are marked *
In which application did you use the antibody? *
Did it work in your application? *
Your review *
Save my name, email, and website in this browser for the next time I comment.
Got a question or need a quote? Message us and we’ll get back to you 48 hours or less.
Lab / Company